Storys zum Thema Science

Folgen
Keine Story zum Thema Science mehr verpassen.
Filtern
  • 05.09.2008 – 11:00

    European Society for Medical Oncology (ESMO)

    33rd ESMO Congress in Stockholm, 12-16 September 2008

    Lugano (ots) - The 33rd ESMO Congress in Stockholm, the premier European congress in Oncology, serves as a meeting place for medical oncologists, as well as a focal point to exchange ideas with colleagues from other disciplines. The Congress Centre will be the venue for interdisciplinary interaction, a teaching ground, and a place to discuss critical issues for European oncology such as cancer research in Europe, the ...

  • 12.06.2008 – 08:50

    AmVac AG

    AmVac AG Begins Research Cooperation with Bayer

    Zug, Catania (ots) - AmVac AG, a Swiss biopharmaceutical company based in Zug, is starting its first research cooperation program with Bayer Innovation GmbH on the development of a new influenza vaccine. Joint research and development work is beginning with the Bayer subsidiary Icon Genetics GmbH on a novel production approach. Antigens are to be produced for the first time in tobacco plants which along with AmVac AG's ...

  • 08.10.2007 – 09:00

    Prionics AG

    Prionics enhances its European presence

    Former Cedi-Diagnostics new affiliate for the Benelux and Nordic markets Zurich (ots) - Prionics, a world leader in farm animal diagnostics, enhances its own presence in Europe targeting the Benelux and Nordic markets with the launch of Prionics Lelystad (Netherlands). The latest affiliate emerges from the former Cedi-Diagnostics B.V. acquired in 2006, a spin-off from today's world-famous Animal Sciences Group of ...

  • 05.09.2007 – 14:42

    Pieris AG

    Pieris validates the use of Anticalins® as ophthalmologic biotherapeutics

    Freising-Weihenstephan, Germany (ots) - Pieris AG, a bio-pharmaceutical company developing Anticalins®, a novel class of targeted human protein therapeutics, today announced successful completion of a series of preclinical studies validating the use of Anticalins® in ophthalmologic disease. The studies reported by Pieris relate to PRS-055, an ...

  • 30.01.2007 – 08:15

    microTEC

    European Industry in Micro- and Nanotechnologies - Ready for take off

    Brussels (ots) - Companies and Institutes from more than 20 countries in Europe met last week for the first Brokerage and Information Event of MINAM, MINAM (Micro- and Nanomanufacturing) is a Subplatform of the European Technology Platform Manufuture. Projects for cooperative research and industrial solutions were presented on 20 topics in nanomaterials, ...

  • 10.01.2007 – 09:15

    Grünenthal GmbH

    Versatis® lidocaine medicated plaster approved by MHRA

    Aachen, Germany (ots) - In the UK, the Medicines and Healthcare products Regulatory Agency (MHRA) has approved Versatis®, a novel 5 % lidocaine medicated plaster, for the treatment of neuropathic pain associated with previous herpes zoster infection (post-herpetic neuralgia, PHN), developed by the German drug company Grünenthal. Following this national approval of Versatis® and its national launch on January, ...

  • 07.12.2006 – 10:40

    AC Immune SA

    Genentech and AC Immune: Exclusive License Agreement

    AC Immune, Ltd. enters into an Exclusive Global License Agreement and Research Collaboration with Genentech, Inc. for Development of Anti-beta-amyloid Antibodies for the Potential Treatment of Alzheimer's Disease and other human Diseases. Ecublens/Lausanne, Switzerland (ots) - AC Immune, Ltd., a Swiss Biotech Company developing innovative therapies against Alzheimer's Disease, today announced that it has entered into ...

  • 12.05.2006 – 08:30

    Università della Svizzera italiana

    Tenth Dies Academicus event held by the Università della Svizzera Italiana (University of Lugano)

    Saturday 13th May 2006 from 10 a.m. to 12.15 p.m. Great Hall (Aula Magna) on the University Campus in Lugano Lugano (ots) - The Università della Svizzera Italiana is 10 years old! The Dies Academicus is an important opportunity to meet up and exchange information about the development of the USI within the context of our region and in its relations with ...

  • 14.03.2005 – 12:00

    The New Diversity Initiative

    Crisis in mass marketing: social diversity is changing the face of marketing

    Zurich (ots) - Globalization is making itself felt not only worldwide but also at the regional level. The growing diversity of modern society is radically altering conditions on consumer markets. This issue was addressed at the first New Diversity Forum, which was held at the Zurich airport from March 13-14. The event, which was jointly sponsored by Lowe Switzerland ...